0(0%) Volume: 175,392 1:15AM EST| Market Cap : 322.08 M | Enterprise Value : 289.7 M | P/E (TTM) : 435.25 | P/B : 7.23 |
|---|
NAS:BLFS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BLFS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash-to-Debt | No Debt |
NAS:BLFS's Cash-to-Debt is ranked higher than
100% of the 205 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.74 vs. NAS:BLFS: No Debt ) Ranked among companies with meaningful Cash-to-Debt only. |
NAS:BLFS'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: No Debt Max: No Debt Current: No Debt |
| Equity-to-Asset | 0.95 |
NAS:BLFS's Equity-to-Asset is ranked higher than
80% of the 196 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 0.60 vs. NAS:BLFS: 0.95 ) Ranked among companies with meaningful Equity-to-Asset only. |
NAS:BLFS'
s Equity-to-Asset Range Over the Past 10 Years
Min: -7.3 Med: 0.51 Max: 0.95 Current: 0.95 |
| Piotroski F-Score: 8 |
|
| Altman Z-Score: 70.47 |
|
| Beneish M-Score: -1.49 |
|
| WACC vs ROIC |
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating Margin % | 13.79 |
NAS:BLFS's Operating Margin % is ranked lower than
73% of the 201 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.41 vs. NAS:BLFS: 13.79 ) Ranked among companies with meaningful Operating Margin % only. |
NAS:BLFS'
s Operating Margin % Range Over the Past 10 Years
Min: -186.31 Med: -54.82 Max: 13.79 Current: 13.79 |
| Net Margin % | 10.42 |
NAS:BLFS's Net Margin % is ranked lower than
83% of the 201 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.18 vs. NAS:BLFS: 10.42 ) Ranked among companies with meaningful Net Margin % only. |
NAS:BLFS'
s Net Margin % Range Over the Past 10 Years
Min: -209.91 Med: -68.14 Max: 10.42 Current: 10.42 |
| ROE % | 7.83 |
NAS:BLFS's ROE % is ranked lower than
91% of the 198 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 5.43 vs. NAS:BLFS: 7.83 ) Ranked among companies with meaningful ROE % only. |
NAS:BLFS'
s ROE % Range Over the Past 10 Years
Min: -117.78 Med: -41.49 Max: 7.83 Current: 7.83 |
| ROA % | 8.94 |
NAS:BLFS's ROA % is ranked lower than
89% of the 206 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.85 vs. NAS:BLFS: 8.94 ) Ranked among companies with meaningful ROA % only. |
NAS:BLFS'
s ROA % Range Over the Past 10 Years
Min: -292.57 Med: -68.23 Max: 8.94 Current: 8.94 |
| ROC (Joel Greenblatt) % | 44.96 |
NAS:BLFS's ROC (Joel Greenblatt) % is ranked lower than
81% of the 204 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 9.63 vs. NAS:BLFS: 44.96 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
NAS:BLFS'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1601.29 Med: -162.79 Max: 44.96 Current: 44.96 |
| 3-Year Revenue Growth Rate | 11.90 |
NAS:BLFS's 3-Year Revenue Growth Rate is ranked lower than
92% of the 170 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.10 vs. NAS:BLFS: 11.90 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
NAS:BLFS'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -49.5 Med: 2.95 Max: 416.2 Current: 11.9 |
| 3-Year EBITDA Growth Rate | 18.20 |
NAS:BLFS's 3-Year EBITDA Growth Rate is ranked lower than
99% of the 155 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 10.00 vs. NAS:BLFS: 18.20 ) Ranked among companies with meaningful 3-Year EBITDA Growth Rate only. |
NAS:BLFS'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -215.9 Med: 7.5 Max: 58.5 Current: 18.2 |
| 3-Year EPS without NRI Growth Rate | 12.20 |
NAS:BLFS's 3-Year EPS without NRI Growth Rate is ranked lower than
92% of the 155 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 12.90 vs. NAS:BLFS: 12.20 ) Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only. |
NAS:BLFS'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0 Med: 8.15 Max: 48.9 Current: 12.2 |
| First Eagle Investment 177,578 sh (New) Jim Simons 443,500 sh (+3.65%) |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
| Guru | Date | Action |
Impact | Price Range (Average)* |
Change from Average | Comment | Current Shares |
|---|
What is Peter Lynch Charts )| Industry: | Medical Instruments & Equipment » Medical Instruments & Supplies NAICS: 339113 SIC: 3841 | |
|---|---|---|
| Compare: | NAS:ATEC, OSTO:SEDANA, OTCPK:NTRB, HKSE:01120, XKRX:104540, ISX:MARK, NAS:LAKE, NAS:EKSO, BKK:TOG, AMEX:BVX, NAS:CFMS, OSTO:BONEX, XMCE:BIO, ASX:GMV, XKRX:241820, ASX:CLV, AMEX:INFU, XPAR:BUP, OTCPK:BFNH, ROCO:4729 » details | |
| Traded in other countries: | BJX1.Germany, | |
| Headquarter Location: | USA |
| vs
industry |
vs
history |
||
|---|---|---|---|
| PE Ratio | 435.25 |
BLFS's PE Ratio is ranked lower than
99.99% of the 125 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 31.70 vs. BLFS: 435.25 ) Ranked among companies with meaningful PE Ratio only. |
BLFS'
s PE Ratio Range Over the Past 10 Years
Min: 237.5 Med: 317 Max: 529.75 Current: 435.25 |
| Forward PE Ratio | 59.88 |
BLFS's Forward PE Ratio is ranked lower than
100% of the 40 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 26.32 vs. BLFS: 59.88 ) Ranked among companies with meaningful Forward PE Ratio only. |
N/A |
| PE Ratio without NRI | 435.25 |
BLFS's PE Ratio without NRI is ranked lower than
99.99% of the 123 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 9999.00 vs. BLFS: 435.25 ) Ranked among companies with meaningful PE Ratio without NRI only. |
BLFS'
s PE Ratio without NRI Range Over the Past 10 Years
Min: 237.5 Med: 317 Max: 529.75 Current: 435.25 |
| PB Ratio | 7.24 |
BLFS's PB Ratio is ranked lower than
90% of the 193 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.45 vs. BLFS: 7.24 ) Ranked among companies with meaningful PB Ratio only. |
BLFS'
s PB Ratio Range Over the Past 10 Years
Min: 1.68 Med: 3.53 Max: 20.89 Current: 7.24 |
| PS Ratio | 17.81 |
BLFS's PS Ratio is ranked lower than
78% of the 192 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.48 vs. BLFS: 17.81 ) Ranked among companies with meaningful PS Ratio only. |
BLFS'
s PS Ratio Range Over the Past 10 Years
Min: 0.76 Med: 3.31 Max: 26.08 Current: 17.81 |
| Price-to-Free-Cash-Flow | 134.97 |
BLFS's Price-to-Free-Cash-Flow is ranked lower than
99.99% of the 74 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 28.61 vs. BLFS: 134.97 ) Ranked among companies with meaningful Price-to-Free-Cash-Flow only. |
BLFS'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 69.32 Med: 134.5 Max: 3500 Current: 134.97 |
| Price-to-Operating-Cash-Flow | 117.64 |
BLFS's Price-to-Operating-Cash-Flow is ranked lower than
99.99% of the 94 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 21.15 vs. BLFS: 117.64 ) Ranked among companies with meaningful Price-to-Operating-Cash-Flow only. |
BLFS'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.38 Med: 88.22 Max: 372.34 Current: 117.64 |
| EV-to-EBIT | 174.09 |
BLFS's EV-to-EBIT is ranked lower than
99.99% of the 121 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 23.93 vs. BLFS: 174.09 ) Ranked among companies with meaningful EV-to-EBIT only. |
BLFS'
s EV-to-EBIT Range Over the Past 10 Years
Min: -237.3 Med: -5.1 Max: 4429.5 Current: 174.09 |
| EV-to-EBITDA | 145.72 |
BLFS's EV-to-EBITDA is ranked lower than
99.99% of the 138 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 19.49 vs. BLFS: 145.72 ) Ranked among companies with meaningful EV-to-EBITDA only. |
BLFS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -700.6 Med: -5.4 Max: 1152.9 Current: 145.72 |
| EV-to-Revenue | 16.63 |
BLFS's EV-to-Revenue is ranked lower than
81% of the 199 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.57 vs. BLFS: 16.63 ) Ranked among companies with meaningful EV-to-Revenue only. |
BLFS'
s EV-to-Revenue Range Over the Past 10 Years
Min: -0.2 Med: 4 Max: 33.5 Current: 16.63 |
| Current Ratio | 18.28 |
BLFS's Current Ratio is ranked higher than
82% of the 200 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.57 vs. BLFS: 18.28 ) Ranked among companies with meaningful Current Ratio only. |
BLFS'
s Current Ratio Range Over the Past 10 Years
Min: 0.09 Med: 2.14 Max: 55 Current: 18.28 |
| Quick Ratio | 16.89 |
BLFS's Quick Ratio is ranked higher than
79% of the 201 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.87 vs. BLFS: 16.89 ) Ranked among companies with meaningful Quick Ratio only. |
BLFS'
s Quick Ratio Range Over the Past 10 Years
Min: 0.04 Med: 1.47 Max: 55 Current: 16.89 |
| Days Inventory | 133.11 |
BLFS's Days Inventory is ranked lower than
68% of the 197 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 124.35 vs. BLFS: 133.11 ) Ranked among companies with meaningful Days Inventory only. |
BLFS'
s Days Inventory Range Over the Past 10 Years
Min: 37.89 Med: 138.59 Max: 193.93 Current: 133.11 |
| Days Sales Outstanding | 56.55 |
BLFS's Days Sales Outstanding is ranked higher than
73% of the 165 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 61.97 vs. BLFS: 56.55 ) Ranked among companies with meaningful Days Sales Outstanding only. |
BLFS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.81 Med: 53.08 Max: 77.03 Current: 56.55 |
| Days Payable | 68.58 |
BLFS's Days Payable is ranked lower than
66% of the 151 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 54.66 vs. BLFS: 68.58 ) Ranked among companies with meaningful Days Payable only. |
BLFS'
s Days Payable Range Over the Past 10 Years
Min: 34.86 Med: 72.62 Max: 311.98 Current: 68.58 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.10 |
BLFS's 3-Year Average Share Buyback Ratio is ranked lower than
92% of the 143 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: -5.00 vs. BLFS: -5.10 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
BLFS'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -77.4 Med: -0.2 Max: 28.4 Current: -5.1 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price-to-Net-Cash | 10.62 |
BLFS's Price-to-Net-Cash is ranked lower than
88% of the 49 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 13.15 vs. BLFS: 10.62 ) Ranked among companies with meaningful Price-to-Net-Cash only. |
BLFS'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.4 Med: 4.6 Max: 63.44 Current: 10.62 |
| Price-to-Net-Current-Asset-Value | 8.88 |
BLFS's Price-to-Net-Current-Asset-Value is ranked lower than
77% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 8.83 vs. BLFS: 8.88 ) Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only. |
BLFS'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.06 Med: 4.42 Max: 61.33 Current: 8.88 |
| Price-to-Tangible-Book | 7.22 |
BLFS's Price-to-Tangible-Book is ranked lower than
81% of the 167 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.77 vs. BLFS: 7.22 ) Ranked among companies with meaningful Price-to-Tangible-Book only. |
BLFS'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.97 Med: 4.63 Max: 49.35 Current: 7.22 |
| Price-to-Intrinsic-Value-Projected-FCF | 31.09 | ||
| Price-to-Median-PS-Value | 5.39 |
BLFS's Price-to-Median-PS-Value is ranked lower than
88% of the 160 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.13 vs. BLFS: 5.39 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
BLFS'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.38 Med: 0.92 Max: 11.13 Current: 5.39 |
| Price-to-Graham-Number | 11.84 |
BLFS's Price-to-Graham-Number is ranked lower than
99.99% of the 94 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.77 vs. BLFS: 11.84 ) Ranked among companies with meaningful Price-to-Graham-Number only. |
BLFS'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 10.99 Med: 11.9 Max: 11.9 Current: 11.84 |
| Earnings Yield (Greenblatt) % | 0.57 |
BLFS's Earnings Yield (Greenblatt) % is ranked lower than
75% of the 207 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.40 vs. BLFS: 0.57 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
BLFS'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -1126.4 Med: -17.7 Max: 2881.8 Current: 0.57 |
| Revenue (TTM) (Mil) $ | 17.42 |
|---|---|
| EPS (TTM) $ | 0.04 |
| Beta | 2.23 |
| Volatility | 101.51% |
| 52-Week Range $ | 4.85 - 26.35 |
| Shares Outstanding (Mil) | 18.50 |
| Dec18 | Dec19 | Dec20 | Dec21 | |
|---|---|---|---|---|
| Revenue (Mil $) | 20 | 28 | 39 | 54 |
| EBIT (Mil $) | ||||
| EBITDA (Mil $) | ||||
| EPS ($) | 0.15 | 0.27 | 0.48 | 0.78 |
| EPS without NRI ($) | 0.15 | 0.27 | 0.48 | 0.78 |
| EPS Growth Rate (Future 3Y To 5Y Estimate) | N/A | |||
| Dividends per Share ($) | ||||
|
GF Chat
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP